These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 9047305

  • 1. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
    Lurtz MM, Hareland ML, Pedersen SE.
    Biochemistry; 1997 Feb 25; 36(8):2068-75. PubMed ID: 9047305
    [Abstract] [Full Text] [Related]

  • 2. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR.
    Arch Biochem Biophys; 1999 Nov 01; 371(1):89-97. PubMed ID: 10525293
    [Abstract] [Full Text] [Related]

  • 3. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):1-11. PubMed ID: 8806747
    [Abstract] [Full Text] [Related]

  • 4. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state.
    Johnson DA, Ayres S.
    Biochemistry; 1996 May 21; 35(20):6330-6. PubMed ID: 8639577
    [Abstract] [Full Text] [Related]

  • 5. Site-selective photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide.
    Pedersen SE.
    Mol Pharmacol; 1995 Jan 21; 47(1):1-9. PubMed ID: 7838117
    [Abstract] [Full Text] [Related]

  • 6. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR, Trudell JR, Bayer EZ, Hester B, McCardy EA, Blanton MP.
    Biochemistry; 2003 Jun 24; 42(24):7358-70. PubMed ID: 12809491
    [Abstract] [Full Text] [Related]

  • 7. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H, McCardy EA, Machu TK, Blanton MP.
    J Pharmacol Exp Ther; 1999 Jul 24; 290(1):129-35. PubMed ID: 10381768
    [Abstract] [Full Text] [Related]

  • 8. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
    Valenzuela CF, Kerr JA, Duvvuri P, Johnson DA.
    Mol Pharmacol; 1992 Feb 24; 41(2):331-6. PubMed ID: 1538711
    [Abstract] [Full Text] [Related]

  • 9. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
    Andreeva IE, Nirthanan S, Cohen JB, Pedersen SE.
    Biochemistry; 2006 Jan 10; 45(1):195-204. PubMed ID: 16388595
    [Abstract] [Full Text] [Related]

  • 10. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
    Amitai G, Herz JM, Bruckstein R, Luz-Chapman S.
    Mol Pharmacol; 1987 Nov 10; 32(5):678-85. PubMed ID: 3683366
    [Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR, Bhumireddy P, Spitzmaul G, Trudell JR, Bouzat C.
    Biochemistry; 2006 Feb 21; 45(7):2014-26. PubMed ID: 16475790
    [Abstract] [Full Text] [Related]

  • 12. Aminotriarylmethane dyes are high-affinity noncompetitive antagonists of the nicotinic acetylcholine receptor.
    Lurtz MM, Pedersen SE.
    Mol Pharmacol; 1999 Jan 21; 55(1):159-67. PubMed ID: 9882710
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
    Min CK, Owens J, Weiland GA.
    Mol Pharmacol; 1994 Feb 21; 45(2):221-7. PubMed ID: 7509439
    [Abstract] [Full Text] [Related]

  • 14. Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
    Groebe DR, Gray WR, Abramson SN.
    Biochemistry; 1997 May 27; 36(21):6469-74. PubMed ID: 9174364
    [Abstract] [Full Text] [Related]

  • 15. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR.
    Biochim Biophys Acta; 1998 Aug 21; 1376(2):173-220. PubMed ID: 9748559
    [Abstract] [Full Text] [Related]

  • 16. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR.
    Mol Membr Biol; 1995 Aug 21; 12(4):339-47. PubMed ID: 8747279
    [Abstract] [Full Text] [Related]

  • 17. Differential agonist-induced displacement of quinacrine and ethidium from their respective histrionicotoxin-sensitive binding sites on the Torpedo acetylcholine receptor.
    Arias HR, Johnson DA.
    Biochemistry; 1995 Feb 07; 34(5):1589-95. PubMed ID: 7849018
    [Abstract] [Full Text] [Related]

  • 18. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC, Xie Y, Cohen JB.
    Biochemistry; 1999 May 18; 38(20):6689-98. PubMed ID: 10350488
    [Abstract] [Full Text] [Related]

  • 19. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP, Xie Y, Dangott LJ, Cohen JB.
    Mol Pharmacol; 1999 Feb 18; 55(2):269-78. PubMed ID: 9927618
    [Abstract] [Full Text] [Related]

  • 20. Interaction of a benzomorphan opiate with acetylcholinesterase and the nicotinic acetylcholine receptor.
    Coleman BA, Michel L, Oswald R.
    Mol Pharmacol; 1987 Oct 18; 32(4):456-62. PubMed ID: 3670280
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.